Metrics as of 10/16/2026, 08:42 AM (Berlin time), refresh in progress.
Haleon Stock
Haleon plc
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United Kingdom
- CEO
- Brian James McNamara
- Employees
- 24,535
- Market cap
- £33 B
- IPO
- 18/07/2022
Haleon plc operates as a global entity within the Healthcare sector, focusing on the development, manufacturing, and marketing of a diverse array of consumer health products. The company is active in the Drug Manufacturers - Specialty & Generic industry and provides solutions across several categories, including…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Haleon stock: price history
1D
+3.5%
1W
+8.9%
1M
+10.1%
6M
+6.3%
YTD
+0.0%
1Y
+9.7%
2Y
-1.7%
5Y
–
10Y
–
Next earnings date
Next earnings date
04/03/2027 (in 138 days)
Volatility around earnings
~49% stronger price swings than usual
Ask the agents about Haleon
Analyst assessment of Haleon
0
STRONG BUY
1
BUY
0
HOLD
0
SELL
0
STRONG SELL
1
TOTAL · Buy
As of: 05/04/2023
Haleon stock metrics
P/E
20.66
P/B
2.04
EV/EBITDA
13.84
RETURN ON EQUITY
2.3%
NET MARGIN
13.6%
DEBT/EQUITY
0.5
DIVIDEND YIELD
1.9%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
95.5%
FLOAT SHARES
8,396,860,702
AVG. DAILY VOLUME (30D)
33,733,970
Dividends
Comparable stocks
Frequently asked questions about Haleon stock
What does Haleon do?
Haleon plc is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in United Kingdom.
The CEO is Brian James McNamara, the company employs around 24,535 people.
The IPO was on 18/07/2022; the stock trades on LSE under the ticker HLN.L.
What do analysts say about Haleon stock?
1 analysts rate the stock, the consensus is Buy (as of 05/04/2023).
This is an external assessment, not a statement by Market Jury.
When does Haleon report next?
The next earnings date is 04/03/2027.
Around past earnings, price swings were roughly 49% stronger than usual.
Does Haleon pay a dividend?
Yes. The last dividend was £2.40 per share, ex-date 13/08/2026, paid on 17/09/2026.
The dividend yield is 1.9% (as of 30/06/2026).
Which stocks are comparable to Haleon?
Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
How can I get Haleon stock analyzed?
Clicking "Analyze stock" lets five strategies assess Haleon against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.